| SELECTIS HEALTH, INC. (GBCSD) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2021-Mar-31 | 2020-Mar-31 | 2019-Mar-31 | 2018-Mar-31 | 2017-Mar-31 | 2016-Mar-31 | 2015-Mar-31 | |||||||||||||||||||||||||||||||||
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2021 | Q3-FY2020 | Q3-FY2019 | Q3-FY2018 | Q3-FY2017 | Q3-FY2016 | Q3-FY2015 | |||||||||||||||||||||||||||||||||
| Operating Cash Flow | 643,970$ | 280,028$ | (77,379$) | 1,035,411$ | (423,361$) | (1,227,653$) | (422,918$) | 249,495$ | (66,995$) | (664,847$) | 252,424$ | 266,139$ | 208,320$ | (101,839$) | (125,963$) | 276,044$ | |||||||||||||||||||||||||||||||||
| Investing Cash Flow | (56,623$) | (4,233$) | (163,515$) | (219,240$) | (9,836$) | 635$ | 2,574,567$ | (116,629$) | (42,515$) | (177,909$) | (1,085,923$) | (954,879$) | (178,021$) | (41,308$) | 573,428$ | 725,526$ | |||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 56,623$ | 4,233$ | 163,515$ | 219,240$ | 9,836$ | (635$) | (89,767$) | 116,629$ | 42,515$ | 177,909$ | 40,156$ | 962,254$ | |||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 42,335$ | (383,707$) | (452,881$) | (182,439$) | 2,567$ | (973,697$) | (161,177$) | (404,750$) | (107,347$) | 654,181$ | 1,079,580$ | (3,828$) | (87,086$) | (41,512$) | (237,969$) | (103,580$) | |||||||||||||||||||||||||||||||||
| End Cash Position | 1,011,632$ | 417,125$ | 559,983$ | 1,288,779$ | 680,332$ | 1,822,596$ | 3,220,581$ | 1,265,613$ | 1,484,599$ | 2,199,743$ | 1,420,200$ | 3,378,862$ | 3,567,437$ | 4,316,683$ | 2,844,515$ | 854,834$ | 641,215$ | 447,945$ | 1,314,364$ | 386,124$ | 1,100,218$ | 818,548$ | 24,670$ | 105,486$ | 154,566$ | 105,485$ | 267,188$ | 434,175$ | 578,242$ | 1,352,015$ | 2,134,673$ | 280,551$ | 71,055$ | 456,464$ | 968,179$ | 533,597$ | 254,880$ | 254,880$ | |||||||||||
| Exchange Rate Effect | |||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | 6,900$ | 7,500$ | 7,500$ | 7,500$ | 7,500$ | 7,500$ | 7,500$ | ||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | 587,347$ | 275,795$ | (240,894$) | 816,171$ | (433,197$) | (1,227,018$) | (333,151$) | 132,866$ | (109,510$) | (842,756$) | 212,268$ | (696,115$) | 208,320$ | (101,839$) | (125,963$) | 276,044$ | |||||||||||||||||||||||||||||||||